OK Cappy, no more diversions, let's get back on topic:
How many Valimed units have been sold? Has CDEx secured funding? These are the immediate questions investors are asking that need to be answered by management.
The meth gun is irrelevant at this point, in fact, it's an expenditure liability with an uncertain future- another carrot "just around the corner" What CDEX needs has to be in it's grasp, not around the corner. What CDEX needs is funding and Valimed sales.
That is the priority news investors are waiting to hear and hopefully they won't have to wait for the next 10Q to decipher the information.
How much funding has been obtained?
How many of the first 25 production Valimed's have been sold?
Straight questions, please give straight answers for once.